{"id": 211231466, "updated": "2022-01-31 13:52:34.201", "metadata": {"title": "Combining positron emission tomography/computed tomography, radiomics, and sentinel lymph node mapping for nodal staging of endometrial cancer patients", "authors": "[{\"middle\":[],\"last\":\"Crivellaro\",\"first\":\"Cinzia\"},{\"middle\":[],\"last\":\"Landoni\",\"first\":\"Claudio\"},{\"middle\":[],\"last\":\"Elisei\",\"first\":\"Federica\"},{\"middle\":[],\"last\":\"Buda\",\"first\":\"Alessandro\"},{\"middle\":[],\"last\":\"Bonacina\",\"first\":\"Manuela\"},{\"middle\":[],\"last\":\"Grassi\",\"first\":\"Tommaso\"},{\"middle\":[],\"last\":\"Monaco\",\"first\":\"Lavinia\"},{\"middle\":[],\"last\":\"Giuliani\",\"first\":\"Daniela\"},{\"middle\":[],\"last\":\"Gotuzzo\",\"first\":\"Irene\"},{\"middle\":[],\"last\":\"Magni\",\"first\":\"Sonia\"},{\"middle\":[],\"last\":\"Di Martino\",\"first\":\"Giampaolo\"},{\"middle\":[],\"last\":\"Delle Marchette\",\"first\":\"Martina\"},{\"middle\":[],\"last\":\"Guerra\",\"first\":\"Luca\"},{\"middle\":[],\"last\":\"Landoni\",\"first\":\"Fabio\"},{\"middle\":[],\"last\":\"Fruscio\",\"first\":\"Robert\"},{\"middle\":[],\"last\":\"Messa\",\"first\":\"Cristina\"},{\"middle\":[],\"last\":\"De Bernardi\",\"first\":\"Elisabetta\"}]", "venue": null, "journal": "International Journal of Gynecologic Cancer", "publication_date": {"year": 2020, "month": null, "day": null}, "abstract": "Objective To evaluate the combination of positron emission tomography/computed tomography (PET/CT) and sentinel lymph node (SLN) biopsy in women with apparent early-stage endometrial carcinoma. The correlation between radiomics features extracted from PET images of the primary tumor and the presence of nodal metastases was also analyzed. Methods From November 2006 to March 2019, 167 patients with endometrial cancer were included. All women underwent PET/CT and surgical staging: 60/167 underwent systematic lymphadenectomy (Group 1) while, more recently, 107/167 underwent SLN biopsy (Group 2) with technetium-99m +blue dye or indocyanine green. Histology was used as standard reference. PET endometrial lesions were segmented (n=98); 167 radiomics features were computed inside tumor contours using standard Image Biomarker Standardization Initiative (IBSI) methods. Radiomics features associated with lymph node metastases were identified (Mann-Whitney test) in the training group (A); receiver operating characteristic (ROC) curves, area under the curve (AUC) values were computed and optimal cut-off (Youden index) were assessed in the test group (B). Results In Group 1, eight patients had nodal metastases (13%): seven correctly ridentified by PET/CT true-positive with one false-negative case. In Group 2, 27 patients (25%) had nodal metastases: 13 true-positive and 14 false-negative. Sensitivity, specificity, accuracy, positive predictive value, and negative predictive value of PET/CT for pelvic nodal metastases were 87%, 94%, 93%, 70%, and 98% in Group 1 and 48%, 97%, 85%, 87%, and 85% in Group 2, respectively. On radiomics analysis a significant association was found between the presence of lymph node metastases and 64 features. Volume-density, a measurement of shape irregularity, was the most predictive feature (p=0001, AUC=0,77, cut-off 0.35). When t esting cut-off in Group B to discriminate metastatic tumors, PET false-negative findings were reduced from 14 to 8 (-43%). Conclusions PET/CT demonstrated high specificity in detecting nodal metastases. SLN and histologic ultrastaging increased false-negative PET/CT findings, reducing the sensitivity of the technique. PET radiomics features of the primary tumor seem promising for predicting the presence of nodal metastases not detected by visual analysis.", "fields_of_study": "[\"Medicine\"]", "external_ids": {"arxiv": null, "mag": "3008224659", "acl": null, "pubmed": "32079712", "pubmedcentral": null, "dblp": null, "doi": "10.1136/ijgc-2019-000945"}}, "content": {"source": {"pdf_hash": "e035f90f9a908c9aeec0f2117627a27e6f881e80", "pdf_src": "BMJ", "pdf_uri": null, "oa_url_match": false, "oa_info": null}, "grobid": {"id": "7529b7605836c737504df2f457d1f637f4d49872", "type": "plain-text", "url": "s3://ai2-s2-pdf-extraction-prod/parse-results/s2orc_worker/e035f90f9a908c9aeec0f2117627a27e6f881e80.txt", "contents": "\nCombining positron emission tomography/ computed tomography, radiomics, and sentinel lymph node mapping for nodal staging of endometrial cancer patients Original research\n2020. 2020\n\nCinzia Crivellaro cinzia.crivellaro@unimib.it \nNuclear Medicine Department\nASST di Monza San Gerardo Hospital\nMonzaLombardiaItaly\n\nClaudio Landoni \nNuclear Medicine Department\nASST di Monza San Gerardo Hospital\nMonzaLombardiaItaly\n\nSchool of Medicine and Surgery\nUniversity of Milan-Biocca\nMonzaLombardiaItaly\n\nFederica Elisei \nNuclear Medicine Department\nASST di Monza San Gerardo Hospital\nMonzaLombardiaItaly\n\nAlessandro Buda \nGynaecologic Oncology Surgical Unit, Obstetrics and Gynaecology Department\nASST-Monza\nSan Gerardo Hospital\nMilanoLombardiaItaly\n\nManuela Bonacina \nUniversity of Milan-Bicocca\nMilanoLombardiaItaly\n\nTommaso Grassi \nGynaecologic Oncology Surgical Unit, Obstetrics and Gynaecology Department\nASST-Monza\nSan Gerardo Hospital\nMilanoLombardiaItaly\n\nLavinia Monaco \nUniversity of Milan-Bicocca\nMilanoLombardiaItaly\n\nDaniela Giuliani \nGynaecologic Oncology Surgical Unit, Obstetrics and Gynaecology Department\nASST-Monza\nSan Gerardo Hospital\nMilanoLombardiaItaly\n\nIrene Gotuzzo \nUniversity of Milan-Bicocca\nMilanoLombardiaItaly\n\nSonia Magni \nUniversity of Milan-Bicocca\nMilanoLombardiaItaly\n\nGiampaolo Di Martino \nGynaecologic Oncology Surgical Unit, Obstetrics and Gynaecology Department\nASST-Monza\nSan Gerardo Hospital\nMilanoLombardiaItaly\n\nMartina Delle Marchette \nUniversity of Milan-Bicocca\nMilanoLombardiaItaly\n\nLuca Guerra \nNuclear Medicine Department\nASST di Monza San Gerardo Hospital\nMonzaLombardiaItaly\n\nSchool of Medicine and Surgery\nUniversity of Milan-Biocca\nMonzaLombardiaItaly\n\nFabio Landoni \nSchool of Medicine and Surgery\nUniversity of Milan-Biocca\nMonzaLombardiaItaly\n\nGynaecologic Oncology Surgical Unit, Obstetrics and Gynaecology Department\nASST-Monza\nSan Gerardo Hospital\nMilanoLombardiaItaly\n\nRobert Fruscio \nSchool of Medicine and Surgery\nUniversity of Milan-Biocca\nMonzaLombardiaItaly\n\nGynaecologic Oncology Surgical Unit, Obstetrics and Gynaecology Department\nASST-Monza\nSan Gerardo Hospital\nMilanoLombardiaItaly\n\nCristina Messa \nUniversity of Milan-Bicocca\nMilanoLombardiaItaly\n\nTecnomed Foundation\nDr Cinzia Crivellaro, Nuclear Medicine\nUniversity of Milan-Bicocca\nMilanoLombardiaItaly\n\nASST di Monza\n20900MonzaLombardiaItaly\n\nElisabetta De Bernardi \nSchool of Medicine and Surgery\nUniversity of Milan-Biocca\nMonzaLombardiaItaly\n\nCombining positron emission tomography/ computed tomography, radiomics, and sentinel lymph node mapping for nodal staging of endometrial cancer patients Original research\n\nInt J Gynecol Cancer\n302020. 202010.1136/ijgc-2019-000945Received 9 October 2019 Revised 31 December 2019 Accepted 6 January 2020 Methods From November 2006 to March 2019, 167378 Correspondence to CC and CL are joint first authors.\nHIGHLIGHTS\u2022 Positron emission tomography/computed tomography (PET/CT) demonstrated high specificity in detecting pelvic node metastases. \u2022 Sentinel lymph node ultrastaging increased false-negative PET/CT findings, reducing the sensitivity of this technique. \u2022 PET radiomics of the primary tumor (volume-density) correlated with nodal status.\n\nAbSTrACT\n\nObjective To evaluate the combination of positron emission tomography/computed tomography (PET/CT) and sentinel lymph node (SLN) biopsy in women with apparent early-stage endometrial carcinoma. The correlation between radiomics features extracted from PET images of the primary tumor and the presence of nodal metastases was also analyzed.\n\n\nMethods From November 2006 to March 2019, 167\n\npatients with endometrial cancer were included. All women underwent PET/CT and surgical staging: 60/167 underwent systematic lymphadenectomy (Group 1) while, more recently, 107/167 underwent SLN biopsy (Group 2) with technetium-99m +blue dye or indocyanine green. Histology was used as standard reference. PET endometrial lesions were segmented (n=98); 167 radiomics features were computed inside tumor contours using standard Image Biomarker Standardization Initiative (IBSI) methods. Radiomics features associated with lymph node metastases were identified (Mann-Whitney test) in the training group (A); receiver operating characteristic (ROC) curves, area under the curve (AUC) values were computed and optimal cut-off (Youden index) were assessed in the test group (B).\n\nresults In Group 1, eight patients had nodal metastases (13%): seven correctly ridentified by PET/CT true-positive with one false-negative case. In Group 2, 27 patients (25%) had nodal metastases: 13 true-positive and 14 false-negative. Sensitivity, specificity, accuracy, positive predictive value, and negative predictive value of PET/ CT for pelvic nodal metastases were 87%, 94%, 93%, 70%, and 98% in Group 1 and 48%, 97%, 85%, 87%, and 85% in Group 2, respectively. On radiomics analysis a significant association was found between the presence of lymph node metastases and 64 features. Volumedensity, a measurement of shape irregularity, was the most predictive feature (p=0001, AUC=0,77, cut-off 0.35). When t esting cut-off in Group B to discriminate metastatic tumors, PET false-negative findings were reduced from 14 to 8 (-43%).\n\nConclusions PET/CT demonstrated high specificity in detecting nodal metastases. SLN and histologic ultrastaging increased false-negative PET/CT findings, reducing the sensitivity of the technique. PET radiomics features of the primary tumor seem promising for predicting the presence of nodal metastases not detected by visual analysis.\n\n\nInTrOduCTIOn\n\nEndometrial cancer is the most common malignancy of the female genital tract in developed countries. 1 Prognosis relies on several characteristics of the primary tumor, such as depth of myometrium invasion, grading, lymphovascular space invasion, and lymph node involvement. 2 The accurate determination of lymph node status and the extent of metastatic disease is crucial in determining the most appropriate adjuvant therapy. Although complete lymphadenectomy is included in the International Federation of Gynecology and Obstetrics (FIGO) staging of endometrial cancer, its prognostic impact remains controversial, especially in those patients with earlystage disease. [3][4][5] Prospective studies have validated sentinel lymph node (SLN) mapping and the corresponding algorithm demonstrated to be accurate with a more favorable morbidity profile with respect to comprehensive nodal dissection, even in patients with high-risk histology. 6 7 With the aim of predicting extrauterine disease pre-operatively and focusing on optimizing surgical planning, several non-invasive techniques have been evaluated, including 18 F-labeled fluoro-2-deoxyglucose (18F-FDG) positron emission tomography/computed tomography (PET/CT). In a recent metanalysis (19 studies, 1431 patients), overall pooled sensitivity and specificity of 18F-FDG PET or PET/CT in detecting lymph node metastasis were 0.68 and 0.96, respectively. 8 PET/CT falsenegative results are due to the limited spatial resolution. Thus, the introduction of SLN biopsy ultrastaging, able to identify micrometastatic deposits, may increase PET/CT false-negative findings. It has been shown for various neoplasms that tumor characteristics on images correlate with tumor molecular phenotype, genotype, and prognosis. The extraction of a large number of features from medical images and the successive mining of these features by means of machine-learning approaches is called radiomics. 9 Radiomics analysis of the uterine primary tumor on pre-operative 18F-FDG PET images may help predict the presence of metastatic lymph nodes, even when they are too small to be detected by PET, thus reducing false-negative results and increasing the sensitivity of the technique. Although preliminary data seem to confirm this hypothesis, 10 a better evaluation restricted to SLN patients and based on tools that respect the recently introduced radiomics guidelines (Image Biomarker Standardization Initiative (IBSI)) 11 is needed. The aim of this study was therefore to evaluate the role of 18F-FDG PET in women with apparent early-stage endometrial cancer considering the introduction of SLN biopsy and the predictive role of primary tumor radiomics.\n\n\nOriginal research\n\n\nMeTHOdS Population\n\nA total of 167 endometrial cancer patients recruited from November 2006 to March 2019 who underwent a pre-operative 18F-FDG PET/ CT scan were included in the study (Table 1).\n\nPET/CT Protocol and Image Analysis Patients were injected with 3.7 MBq/kg of 18F-FDG. PET/CT scans were performed according to the standard European Association of Nuclear Medicine (EANM) protocol 11 using integrated PET/CT systems (Discovery ST, Discovery 600, or Discovery IQ; GE Healthcare, Milwaukee, WI, USA). Image readout was performed on an Advantage Workstation 4.6 (GE Healthcare) by two nuclear medicine physicians. The diagnosis of lymph node involvement assessed on PET images was based on evidence of pathologic tracer uptake into lymph node sites identified in CT images, regardless of their size at CT.\n\n\nSurgical Treatment\n\nSurgical standard treatment by open or mini-invasive surgery included peritoneal cytology, total hysterectomy, and bilateral salpingo-oophorectomy. Systematic pelvic lymph node dissection included external iliac, superficial, and deep obturator nodes and superficial and deep common iliac nodes. SLN mapping was performed using technetium-99m (Tc-99m) plus blue dye or blue dye alone until 2014, 12 whereas from 2014 onwards fluorescent dye utilising indocyanine green (ICG) (Pulsion Medical Systems SE, Feldkirchen, Germany) was incorporated into our practice. 13 The SLN algorithm of the Memorial Sloan Kettering Cancer Center was applied, implying that any suspicious nodes should be removed regardless of mapping. A full aortic nodal dissection (precaval and paracaval, superficial and deep intercavo-aortic and para-aortic up to renal vessels) was performed in patients with suspected 18F-FDG PET/CT findings, positive PET/CT in the pelvic area in both groups, or detection of suspicious aortic node enlargement at surgery.\n\n\nStandard of Reference and Histopathologic Evaluation\n\nHistopathologic findings were analyzed by an experienced pathologist and served as the standard of reference. In patients subjected to SLN analysis, SLNs were assessed in a standardized manner by ultrastaging and examined by immunochemistry. 12 First Analysis: Assessment of FDG-PET Performances Before/After SLN Biopsy Introduction Women were divided into two groups, depending on the adopted surgical staging. Group 1 included the 60/167 patients who underwent systematic lymphadenectomy and Group 2 the more recent 107/167 patients who underwent SLN biopsy with Tc-99m+blue dye or ICG. Absolute and percentage frequencies were used to describe categoric items of patients' population. Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy of PET/CT imaging in the diagnosis of pelvic lymph node metastases were calculated based on per patient analyses.\n\nSecond Analysis: Assessment of FDG-PET Primary Tumor Radiomics Radiomics analysis was considered only for patients with a 'sure' histologic analysis, that is, patients with SLN biopsy (Group 2, 107     11 The 97 analyzed patients were divided into two groups: a training group for predictive radiomics feature identification (Group A) and a test group for predictive radiomics feature assessment (Group B). Group A included 17 true-positive and 52 true-negative patients. Group B included 14 false-negative (ie, micrometastasis) and 14 true-negative patients. For Group A, univariate association between PET radiomics features and presence of lymph node metastases was computed by Mann-Whitney test; receiver operating characteristic (ROC) curves and area under the curve (AUC) values were also computed.\n\nFeature selection was done considering features with p\u22640.05 and Spearman correlation with already selected features <0.5. Optimal cut-off for selected features was computed with the Youden index. Identified features and cut-offs were assessed in Group B.\n\n\nreSuLTS\n\n\nFirst Analysis\n\nIn Group 1, eight patients had nodal metastases (13%): seven were identified by PET/CT (true-positive) while one was not identified (false-negative). In Group 2, 27 patients were found to have nodal metastases (25%): PET gave 13 true-positive and 14 false-negative. Globally, the percentage of PET false-negatives was 1.6% in Group 1 and 13% in Group 2. Sensitivity, specificity, accuracy, PPV, and NPV of PET/CT for pelvic nodal metastases in Groups 1 and 2 are described in Table 2. Figures 1 and 2 show some clinical cases.\n\n\nSecond Analysis\n\nIn the training dataset (Group A) 64/167 features resulted associated with lymph node metastasis presence with p<0.05. In Table 3, P values and AUCs are shown for a group of features, including conventional PET features (metabolic tumor volume (MTV), total lesion glycolysis (TLG), standardized uptake value (SUV) maximum and mean inside the tumor), two morphologic features (solidity and volume-density) and two size zone matrix (SZM) texture features (SZM zone percentage and gray level non-uniformity (GLNU); https:// arxiv. org/ abs/ 1612. 07003). After feature selection, only one remained: volume-density, which is a morphologic feature, also called extent, defined as the ratio between the tumor volume and the volume of the smallest box containing the tumor. It generally assumes lower values for tumors with an irregular shape, which seem to have a greater probability of developing lymph node metastases. The optimal cut-off for volume-density in Group A was 0.35 (ie, tumors with a volumedensity <0.35 were more likely to be associated with lymph node metastasis). The ability of volume-density to discriminate metastatic tumors was assessed in Group B patients and the results are reported in Table 4. dISCuSSIOn SLN biopsy was shown to improve the detection of metastases by identifying lymph nodes outside the locations traditionally explored with lymphadenectomy, and by identifying low-volume disease. Indeed, ultrastaging analysis leads to a higher detection rate of micrometastases (metastatic deposits <2 mm) and isolated tumor cells 14 that might be otherwise missed by standard histologic analysis. Our study confirmed that the incidence of nodal metastases increased from 13% in the group of patients submitted to standard lymphadenectomy to 25% in the group of patients who underwent SLN biopsy. Furthermore, even if prospective data are needed to verify the reliability and the applicability of this SLN strategy in routine practice over standard lymphadenectomy in high-risk subgroups of women, [15][16][17] there is also new evidence of promising results in this subgroup of patients with apparently confined endometrial cancer.\n\n\nOriginal research\n\nPrevious studies demonstrated high sensitivity of pre-operative PET/CT 8 for lymph node staging especially for high-risk histology; 18 similarly, high sensitivity was found in Group 1 patients (sensitivity 87%). However, these values were probably a forced overestimation because in the gold standard ('standard' histologic analysis) micrometastases were not evident. Considering SLN as the gold standard (Group 2) the sensitivity of the PET/CT technique fell from 87% to 48%.\n\nIndeed, small metastatic lymph node lesions may remain undetected in pre-operative PET/CT scans because of limited spatial resolution (5 mm) and associated partial volume effects. 16 We obtained a higher rate of false-negative PET/CT findings when SLN was used as a gold standard (ie, from 1.6% to 13%). Considering the low sensitivity of the PET/CT technique, radiomics analysis of 18F-FDG distribution inside the primary uterine lesion was performed with the aim of helping to detect suspicious nodal metastases.\n\nA preliminary radiomics analysis in a smaller population demonstrated that uterine tumors with a more heterogeneous FDG uptake were more likely to spread to the pelvic lymph nodes. 10 In particular, the co-presence of high and low uptake areas in the tumor (assessed by SZM ZP) was found to be associated with the presence of nodal metastases at histology, even if a pre-operative PET/ CT scan gave a negative result at the nodal level. However, this analysis was tainted as there were patients who did not undergo SLN biopsy. Furthermore, the extraction of the features in the previous study was performed with a tool that did not respect the more recently introduced IBSI standards. Here we performed the analysis on patients undergoing SLN biopsy and with tools that respected IBSI standards. Compared with previous studies, we confirmed the predictive role of MTV and TLG. Again, SUVmax was not significantly correlated with lymph node status, although it is the most widely used PET parameter in clinical practice and it is considered as an important indicator that reflects tumor aggressiveness. Among radiomics features describing the heterogeneity of uptake, SZM ZP was also confirmed to be correlated to the presence of nodal metastases; however, SZM GLNU (representing the non-uniformity of level of FDG uptake in the lesion) gave superior results to ZP. Finally, tumors with lymph node metastases were found to be generally characterized by an irregular shape and the most predictive index turned out to be volume-density. Our analysis showed that the more irregular the lesion (volume-density <0.35), the more likely the lymph nodes are pathologic. Similarly, previous studies evaluating CT imaging in head and neck cancer have found that irregularly shaped tumors were associated with a worse overall survival rate, which may reflect an increase in their aggressive behavior. 19 20 In this study we suggest integrating radiomics and the results of lymph node metastases visual detection to reduce false-negative results for a more personalized and effective surgical treatment selection. The combination of PET/CT and SLN mapping has been proposed to minimize complications and to maximize lymph node status and cure rate definition. 18 The high PPV of FDG PET allows patients positive at lymph node visual detection to be directed to lymphadenectomy, with the aim of debulking, thus avoiding SLN biopsy. Similarly, SLN biopsy is not indicated in breast cancer patients if pathologic axillary nodes are clinically evident. 21 In addition, PET/CT could be of benefit for patients in whom access to the operative field may be partly compromised (eg, patients with elevated body mass index), where the identification of enlarged or suspicious lymph nodes either in the pelvic or aortic area can be challenging or hampered by the general constitution and physical build of the patients.\n\nHowever, in the case of a negative PET scan, microdisease cannot be excluded. As the prognostic value of low-volume lymph node metastases and the optimum management of this finding are not yet established, patients with isolated tumor cells and micrometastases received adjuvant chemotherapy more frequently and showed a better oncologic outcome when compared with patients with macrometastasis over a time period of 3 years. 22 23 The optimal treatment would be to carry out SLN biopsy and ultrastaging in all patients with early-stage endometrial cancer; however, this technique is not yet in widespread use in all hospitals. The\n\n\nOriginal research\n\nhigh sensitivity of the SLN algorithm for nodal staging has been demonstrated and it is not increased by the introduction of PET/ CT. Until the SLN technique becomes more widespread, radiomics could help in further stratifying the risk of nodal metastases, thus optimizing available resources. Negative PET patients with low volume-density appear to be more likely to have micrometastases and should therefore be referred for SLN biopsy and ultrastaging in tertiary-level specialized hospitals.\n\nThe main limitation of our study resides in the small number of patients. In addition, the definition of features cut-off in the training group containing macrometastases may be not optimal when used to evaluate the presence of micrometastases. However, if we apply the radiomics cut-off to negative PET results, we can identify more metastatic patients (ie, a 43% increase from 0/14 to 6/14 patients).\n\nIn conclusion, PET/CT demonstrated high specificity in detecting pelvic node metastases. SLN biopsy and histologic ultrastaging increased false-negative PET/CT findings, reducing the sensitivity of this imaging technique. PET radiomics features of the primary tumor were significantly correlated with nodal status, in particular volume-density, and could be useful in predicting the presence of nodal metastases not detected on visual analysis. However, larger prospective and cost-effective analyses are needed to clarify the clinical impact of the combination of these techniques.\n\nFigure 1\n1True-positive PET/CT finding. Pathologic 18 Flabeled fluoro-2-deoxyglucose (18-FDG) uptake in a small left external iliac lymph node, confirmed at histology.\n\nFigure 2\n2False-negative PET/CT finding. No pathologic uptake was detected, while sentinel lymph node biopsy and ultrastaging demonstrated a micrometastases in the left external iliac site.\n\nTable 1\n1Patients' characteristics (n=167 patients).Characteristic \nn (%) \n\nAge (years) (mean\u00b1SD) \n63.3\u00b110.9 \nGrading \n\nG1 \n26 (15.6) \n\nG2 \n67 (40.1) \n\nG3 \n73 (44.3) \n\nHistotype \n\nEndometrioid \n134 (80.2) \n\nMixed \n7 (4.2) \n\nNon-endometrioid/serous/clear cell \n15 (9.0) \n\nMalignant mixed Mullerian tumor \n11 (6.6) \n\nMyometrial invasion \n\n<50% \n85 (50.9) \n\n>50% \n76 (45.5) \n\nNot available \n6 (3.6) \n\nNodal metastases \n\nYes \n35 (21.0) \n\nNo \n132 (79.0) \n\nFIGO staging \n\nI \n102 (61.1) \n\nII \n17 (10.1) \n\nIII \n41 (24.6) \nIV \n7 (4.2) \n\nFIGO, International Federation of Gynecology and Obstetrics. \n\n\n\nTable 2\n2PET/CT performance in detecting pelvic nodal metastasesParameter \n\nGroup 1 \n-no SLN \nbiopsy \n(n=60) \n\nGroup 2 \n-SLN \nbiopsy \n(n=107) \n\nLymph node metastasis \n8 (13%) \n27 (25%) \nTP \n7 (12%) \n13 (12%) \n\nTN \n49 (82%) \n78 (73%) \n\nFP \n3 (5%) \n2 (2%) \n\nFN \n1 (2%) \n14 (13%) \n\nSensitivity: TP/(TP+FN) \n87% \n48% \n\nSpecificity: TN/(TN+FP) \n94% \n97% \n\nNPV: TN/(TN+FN) \n98% \n85% \n\nPPV: TP/(TP+FP) \n70% \n87% \nAccuracy: (TP+TN)/total \n93% \n85% \n\nFN, false-negative; FP, false-positive; NPV, negative predictive \nvalue; PPV, positive predictive value; SLN, sentinel lymph node; \nTN, true-negative; TP, true-positive. \n\n\n\nTable 3\n3Univariate radiomics analysisFeature name \nP value \nAUC \n\nMTV \n0.015 \n0.70 \nTLG \n0.016 \n0.70 \n\nSUV mean \n0.166 \n0.61 \n\nSUV maximum \n0.158 \n0.62 \n\nSolidity \n0.011 \n0.71 \n\nVolume-density \n0.001 \n0.77 \n\nSZM ZP \n0.040 \n0.67 \nSZM GLNU \n0.009 \n0.71 \n\nAUC, area under the curve; GLNU, gray level non-uniformity; MTV, \nmetabolic tumor volume; SUV, standardized uptake value; SZM, \nsize zone matrix; TLG, total lesion glycolysis; ZP, zone percentage. \n\n\n\nTable 4\n4Ability of volume-density to discriminate metastatic tumors in Group B patients (n=28; 14 with metastatic nodes, 14 without metastatic nodes)Result \nPET visual detection (n) PET radiomics \n\nTP \n0 \n6 \nTN \n14 \n13 \n\nFP \n0 \n1 \nFN \n14 \n8 \n\nFN, false-negative; FP, false-positive; PET, positron emission \ntomography; TN, true-negative; TP, true-positive. \n\n\nAcknowledgements The authors want to thank Patricia Ann Sawchuk for her friendship and valuable contribution to the final revision of the article. Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.editor's note This paper will feature in a special issue on sentinel lymph node mapping in 2020.Competing interests None declared.Patient consent for publication Not required.ethics approval All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.Provenance and peer review Commissioned; externally peer reviewed. data availability statement Data are available upon reasonable request.reFerenCeS\nCancer statistics. R L Siegel, K D Miller, A Jemal, 10.3322/caac.21387CA Cancer J Clin. 67Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin 2017;67:7-30.\n\nEndometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. N Colombo, E Preti, F Landoni, 10.1093/annonc/mdr374Ann Oncol. 22Colombo N, Preti E, Landoni F, et al. Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2011;22:vi35-9.\n\nSecondary analyses from a randomized clinical trial: age as the key prognostic factor in endometrial carcinoma. P Benedetti Panici, S Basile, M G Salerno, 10.1016/j.ajog.2013.12.025Am J Obstet Gynecol. 210e10Benedetti Panici P, Basile S, Salerno MG, et al. Secondary analyses from a randomized clinical trial: age as the key prognostic factor in endometrial carcinoma. Am J Obstet Gynecol 2014;210:363.e1-363. e10.\n\nEfficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. H Kitchener, Amc Swart, Q Qian, 10.1016/S0140-6736(08)61766-3Lancet. 373Kitchener H, Swart AMC, Qian Q, et al. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet 2009;373:125-36.\n\nThe American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. S B Edge, C C Compton, 10.1245/s10434-010-0985-4Ann Surg Oncol. 17Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 2010;17:1471-4.\n\nA comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study. E C Rossi, L D Kowalski, J Scalici, 10.1016/S1470-2045(17)30068-2Lancet Oncol. 18Rossi EC, Kowalski LD, Scalici J, et al. A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study. Lancet Oncol 2017;18:384-92.\n\nSentinel lymph node mapping and staging in endometrial cancer: a Society of Gynecologic Oncology literature review with consensus recommendations. R W Holloway, N R Abu-Rustum, F J Backes, 10.1016/j.ygyno.2017.05.027Gynecol Oncol. 146Holloway RW, Abu-Rustum NR, Backes FJ, et al. Sentinel lymph node mapping and staging in endometrial cancer: a Society of Gynecologic Oncology literature review with consensus recommendations. Gynecol Oncol 2017;146:405-15.\n\nDiagnostic accuracy of preoperative 18F-FDG PET or PET/CT in detecting pelvic and para-aortic lymph node metastasis in patients with endometrial cancer: a systematic review and meta-analysis. J Hu, K Zhang, Y Yan, 10.1007/s00404-019-05207-8Arch Gynecol Obstet. 300Hu J, Zhang K, Yan Y, et al. Diagnostic accuracy of preoperative 18F-FDG PET or PET/CT in detecting pelvic and para-aortic lymph node metastasis in patients with endometrial cancer: a systematic review and meta-analysis. Arch Gynecol Obstet 2019;300:519-29.\n\nRadiomics: data are also images. M Hatt, Le Rest, C C Tixier, F , 10.2967/jnumed.118.220582J Nucl Med. 60Hatt M, Le Rest CC, Tixier F, et al. Radiomics: data are also images. J Nucl Med 2019;60:38S-44.\n\nRadiomics of the primary tumour as a tool to improve 18F-FDG-PET sensitivity in detecting nodal metastases in endometrial cancer. De Bernardi, E Buda, A Guerra, L , 10.1186/s13550-018-0441-1EJNMMI Res. 886De Bernardi E, Buda A, Guerra L, et al. Radiomics of the primary tumour as a tool to improve 18F-FDG-PET sensitivity in detecting nodal metastases in endometrial cancer. EJNMMI Res 2018;8:86.\n\nFDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0. R Boellaard, R Delgado-Bolton, Wjg Oyen, 10.1007/s00259-014-2961-xEur J Nucl Med Mol Imaging. 42Boellaard R, Delgado-Bolton R, Oyen WJG, et al. FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging 2015;42:328-54.\n\nIntegration of hybrid single-photon emission computed tomography/computed tomography in the preoperative assessment of sentinel node in patients with cervical and endometrial cancer: our experience and literature review. A Buda, F Elisei, M Arosio, 10.1097/IGC.0b013e318253496fInt J Gynecol Cancer. 22Buda A, Elisei F, Arosio M, et al. Integration of hybrid single-photon emission computed tomography/computed tomography in the preoperative assessment of sentinel node in patients with cervical and endometrial cancer: our experience and literature review. Int J Gynecol Cancer 2012;22:830-5.\n\nImpact of indocyanine green for sentinel lymph node mapping in early stage endometrial and cervical cancer: comparison with conventional radiotracer 99mTc and/or blue dye. A Buda, C Crivellaro, F Elisei, 10.1245/s10434-015-5022-1Ann Surg Oncol. 23Buda A, Crivellaro C, Elisei F, et al. Impact of indocyanine green for sentinel lymph node mapping in early stage endometrial and cervical cancer: comparison with conventional radiotracer 99mTc and/or blue dye. Ann Surg Oncol 2016;23:2183-91.\n\nSentinel lymph node mapping for endometrial cancer improves the detection of metastatic disease to regional lymph nodes. F Khoury-Collado, M P Murray, M L Hensley, 10.1016/j.ygyno.2011.04.030Gynecol Oncol. 122Khoury-Collado F, Murray MP, Hensley ML, et al. Sentinel lymph node mapping for endometrial cancer improves the detection of metastatic disease to regional lymph nodes. Gynecol Oncol 2011;122:251-4.\n\nA prospective validation study of sentinel lymph node mapping for high-risk endometrial cancer. P T Soliman, S N Westin, S Dioun, 10.1016/j.ygyno.2017.05.016Gynecol Oncol. 146Soliman PT, Westin SN, Dioun S, et al. A prospective validation study of sentinel lymph node mapping for high-risk endometrial cancer. Gynecol Oncol 2017;146:234-9.\n\nLymph node evaluation in high-risk early stage endometrial cancer: a multi-institutional retrospective analysis comparing the sentinel lymph node (SLN) algorithm and SLN with selective lymphadenectomy. A Buda, M L Gasparri, A Puppo, 10.1016/j.ygyno.2018.06.003Gynecol Oncol. 150Buda A, Gasparri ML, Puppo A, et al. Lymph node evaluation in high-risk early stage endometrial cancer: a multi-institutional retrospective analysis comparing the sentinel lymph node (SLN) algorithm and SLN with selective lymphadenectomy. Gynecol Oncol 2018;150:261-6.\n\nPelvic Sentinel lymph node detection in High-Risk Endometrial Cancer (SHREC-trial)-the final step towards a paradigm shift in surgical staging. J Persson, S Salehi, M Bollino, 10.1016/j.ejca.2019.04.025Eur J Cancer. 116Persson J, Salehi S, Bollino M, et al. Pelvic Sentinel lymph node detection in High-Risk Endometrial Cancer (SHREC-trial)-the final step towards a paradigm shift in surgical staging. Eur J Cancer 2019;116:77-85.\n\nStaging of high-risk endometrial cancer with PET/CT and sentinel lymph node mapping. M Signorelli, C Crivellaro, A Buda, 10.1097/RLU.0000000000000852Clin Nucl Med. 40Signorelli M, Crivellaro C, Buda A, et al. Staging of high-risk endometrial cancer with PET/CT and sentinel lymph node mapping. Clin Nucl Med 2015;40:780-5.\n\nImproving the prediction of overall survival for head and neck cancer patients using image biomarkers in combination with clinical parameters. T-T Zhai, L V Van Dijk, B-T Huang, 10.1016/j.radonc.2017.07.013Radiother Oncol. 124Zhai T-T, van Dijk LV, Huang B-T, et al. Improving the prediction of overall survival for head and neck cancer patients using image biomarkers in combination with clinical parameters. Radiother Oncol 2017;124:256-62.\n\nTumor volume predicts survival rate of advanced nasopharyngeal carcinoma treated with concurrent chemoradiotherapy. L Qin, F Wu, H Lu, 10.1177/0194599816644408Otolaryngol Head Neck Surg. 155Qin L, Wu F, Lu H, et al. Tumor volume predicts survival rate of advanced nasopharyngeal carcinoma treated with concurrent chemoradiotherapy. Otolaryngol Head Neck Surg 2016;155:598-605.\n\nEarly breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. F Cardoso, S Kyriakides, S Ohno, 10.1093/annonc/mdz173Ann Oncol. 30Cardoso F, Kyriakides S, Ohno S, et al. Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2019;30:1194-220.\n\nSentinel lymph node mapping with staging lymphadenectomy for patients with endometrial cancer increases the detection of metastasis. R W Holloway, S Gupta, N M Stavitzski, 10.1016/j.ygyno.2016.02.018Gynecol Oncol. 141Holloway RW, Gupta S, Stavitzski NM, et al. Sentinel lymph node mapping with staging lymphadenectomy for patients with endometrial cancer increases the detection of metastasis. Gynecol Oncol 2016;141:206-10.\n\nLow-volume lymph node metastasis discovered during sentinel lymph node mapping for endometrial carcinoma. St, C M Clair, Agz Eriksson, J A Ducie, 10.1245/s10434-015-5040-zAnn Surg Oncol. 23St. Clair CM, Eriksson AGZ, Ducie JA, et al. Low-volume lymph node metastasis discovered during sentinel lymph node mapping for endometrial carcinoma. Ann Surg Oncol 2016;23:1653-9.\n", "annotations": {"author": "[{\"start\":\"184\",\"end\":\"314\"},{\"start\":\"315\",\"end\":\"494\"},{\"start\":\"495\",\"end\":\"595\"},{\"start\":\"596\",\"end\":\"741\"},{\"start\":\"742\",\"end\":\"809\"},{\"start\":\"810\",\"end\":\"954\"},{\"start\":\"955\",\"end\":\"1020\"},{\"start\":\"1021\",\"end\":\"1167\"},{\"start\":\"1168\",\"end\":\"1232\"},{\"start\":\"1233\",\"end\":\"1295\"},{\"start\":\"1296\",\"end\":\"1446\"},{\"start\":\"1447\",\"end\":\"1521\"},{\"start\":\"1522\",\"end\":\"1697\"},{\"start\":\"1698\",\"end\":\"1920\"},{\"start\":\"1921\",\"end\":\"2144\"},{\"start\":\"2145\",\"end\":\"2359\"},{\"start\":\"2360\",\"end\":\"2462\"}]", "publisher": null, "author_last_name": "[{\"start\":\"191\",\"end\":\"201\"},{\"start\":\"323\",\"end\":\"330\"},{\"start\":\"504\",\"end\":\"510\"},{\"start\":\"607\",\"end\":\"611\"},{\"start\":\"750\",\"end\":\"758\"},{\"start\":\"818\",\"end\":\"824\"},{\"start\":\"963\",\"end\":\"969\"},{\"start\":\"1029\",\"end\":\"1037\"},{\"start\":\"1174\",\"end\":\"1181\"},{\"start\":\"1239\",\"end\":\"1244\"},{\"start\":\"1309\",\"end\":\"1316\"},{\"start\":\"1461\",\"end\":\"1470\"},{\"start\":\"1527\",\"end\":\"1533\"},{\"start\":\"1704\",\"end\":\"1711\"},{\"start\":\"1928\",\"end\":\"1935\"},{\"start\":\"2154\",\"end\":\"2159\"},{\"start\":\"2371\",\"end\":\"2382\"}]", "author_first_name": "[{\"start\":\"184\",\"end\":\"190\"},{\"start\":\"315\",\"end\":\"322\"},{\"start\":\"495\",\"end\":\"503\"},{\"start\":\"596\",\"end\":\"606\"},{\"start\":\"742\",\"end\":\"749\"},{\"start\":\"810\",\"end\":\"817\"},{\"start\":\"955\",\"end\":\"962\"},{\"start\":\"1021\",\"end\":\"1028\"},{\"start\":\"1168\",\"end\":\"1173\"},{\"start\":\"1233\",\"end\":\"1238\"},{\"start\":\"1296\",\"end\":\"1305\"},{\"start\":\"1306\",\"end\":\"1308\"},{\"start\":\"1447\",\"end\":\"1454\"},{\"start\":\"1455\",\"end\":\"1460\"},{\"start\":\"1522\",\"end\":\"1526\"},{\"start\":\"1698\",\"end\":\"1703\"},{\"start\":\"1921\",\"end\":\"1927\"},{\"start\":\"2145\",\"end\":\"2153\"},{\"start\":\"2360\",\"end\":\"2370\"}]", "author_affiliation": "[{\"start\":\"231\",\"end\":\"313\"},{\"start\":\"332\",\"end\":\"414\"},{\"start\":\"416\",\"end\":\"493\"},{\"start\":\"512\",\"end\":\"594\"},{\"start\":\"613\",\"end\":\"740\"},{\"start\":\"760\",\"end\":\"808\"},{\"start\":\"826\",\"end\":\"953\"},{\"start\":\"971\",\"end\":\"1019\"},{\"start\":\"1039\",\"end\":\"1166\"},{\"start\":\"1183\",\"end\":\"1231\"},{\"start\":\"1246\",\"end\":\"1294\"},{\"start\":\"1318\",\"end\":\"1445\"},{\"start\":\"1472\",\"end\":\"1520\"},{\"start\":\"1535\",\"end\":\"1617\"},{\"start\":\"1619\",\"end\":\"1696\"},{\"start\":\"1713\",\"end\":\"1790\"},{\"start\":\"1792\",\"end\":\"1919\"},{\"start\":\"1937\",\"end\":\"2014\"},{\"start\":\"2016\",\"end\":\"2143\"},{\"start\":\"2161\",\"end\":\"2209\"},{\"start\":\"2211\",\"end\":\"2318\"},{\"start\":\"2320\",\"end\":\"2358\"},{\"start\":\"2384\",\"end\":\"2461\"}]", "title": "[{\"start\":\"1\",\"end\":\"171\"},{\"start\":\"2463\",\"end\":\"2633\"}]", "venue": "[{\"start\":\"2635\",\"end\":\"2655\"}]", "abstract": "[{\"start\":\"2867\",\"end\":\"3208\"}]", "bib_ref": "[{\"start\":\"5679\",\"end\":\"5680\",\"attributes\":{\"ref_id\":\"b0\"}},{\"start\":\"5853\",\"end\":\"5854\",\"attributes\":{\"ref_id\":\"b1\"}},{\"start\":\"6249\",\"end\":\"6252\",\"attributes\":{\"ref_id\":\"b2\"}},{\"start\":\"6252\",\"end\":\"6255\",\"attributes\":{\"ref_id\":\"b3\"}},{\"start\":\"6255\",\"end\":\"6258\",\"attributes\":{\"ref_id\":\"b4\"}},{\"start\":\"6519\",\"end\":\"6522\"},{\"start\":\"6990\",\"end\":\"6991\",\"attributes\":{\"ref_id\":\"b7\"}},{\"start\":\"7517\",\"end\":\"7518\",\"attributes\":{\"ref_id\":\"b8\"}},{\"start\":\"9526\",\"end\":\"9528\",\"attributes\":{\"ref_id\":\"b11\"}},{\"start\":\"9692\",\"end\":\"9694\",\"attributes\":{\"ref_id\":\"b12\"}},{\"start\":\"10457\",\"end\":\"10459\",\"attributes\":{\"ref_id\":\"b11\"}},{\"start\":\"11325\",\"end\":\"11327\",\"attributes\":{\"ref_id\":\"b10\"}},{\"start\":\"14778\",\"end\":\"14782\",\"attributes\":{\"ref_id\":\"b14\"}},{\"start\":\"14782\",\"end\":\"14786\",\"attributes\":{\"ref_id\":\"b15\"}},{\"start\":\"14786\",\"end\":\"14790\",\"attributes\":{\"ref_id\":\"b16\"}},{\"start\":\"15066\",\"end\":\"15068\",\"attributes\":{\"ref_id\":\"b17\"}},{\"start\":\"15592\",\"end\":\"15594\",\"attributes\":{\"ref_id\":\"b15\"}},{\"start\":\"16109\",\"end\":\"16111\",\"attributes\":{\"ref_id\":\"b9\"}},{\"start\":\"17817\",\"end\":\"17822\"},{\"start\":\"18175\",\"end\":\"18177\",\"attributes\":{\"ref_id\":\"b17\"}},{\"start\":\"18464\",\"end\":\"18466\",\"attributes\":{\"ref_id\":\"b20\"}},{\"start\":\"19251\",\"end\":\"19253\",\"attributes\":{\"ref_id\":\"b21\"}},{\"start\":\"19254\",\"end\":\"19256\",\"attributes\":{\"ref_id\":\"b22\"}}]", "figure": "[{\"start\":\"20961\",\"end\":\"21129\",\"attributes\":{\"id\":\"fig_0\"}},{\"start\":\"21130\",\"end\":\"21320\",\"attributes\":{\"id\":\"fig_1\"}},{\"start\":\"21321\",\"end\":\"21913\",\"attributes\":{\"id\":\"tab_0\",\"type\":\"table\"}},{\"start\":\"21914\",\"end\":\"22529\",\"attributes\":{\"id\":\"tab_1\",\"type\":\"table\"}},{\"start\":\"22530\",\"end\":\"22984\",\"attributes\":{\"id\":\"tab_2\",\"type\":\"table\"}},{\"start\":\"22985\",\"end\":\"23346\",\"attributes\":{\"id\":\"tab_3\",\"type\":\"table\"}}]", "paragraph": "[{\"start\":\"3220\",\"end\":\"3559\"},{\"start\":\"3609\",\"end\":\"4382\"},{\"start\":\"4384\",\"end\":\"5223\"},{\"start\":\"5225\",\"end\":\"5561\"},{\"start\":\"5578\",\"end\":\"8270\"},{\"start\":\"8313\",\"end\":\"8487\"},{\"start\":\"8489\",\"end\":\"9107\"},{\"start\":\"9130\",\"end\":\"10158\"},{\"start\":\"10215\",\"end\":\"11121\"},{\"start\":\"11123\",\"end\":\"11927\"},{\"start\":\"11929\",\"end\":\"12183\"},{\"start\":\"12212\",\"end\":\"12738\"},{\"start\":\"12758\",\"end\":\"14912\"},{\"start\":\"14934\",\"end\":\"15410\"},{\"start\":\"15412\",\"end\":\"15926\"},{\"start\":\"15928\",\"end\":\"18823\"},{\"start\":\"18825\",\"end\":\"19456\"},{\"start\":\"19478\",\"end\":\"19972\"},{\"start\":\"19974\",\"end\":\"20376\"},{\"start\":\"20378\",\"end\":\"20960\"}]", "formula": null, "table_ref": "[{\"start\":\"8477\",\"end\":\"8486\",\"attributes\":{\"ref_id\":\"tab_0\"}},{\"start\":\"12688\",\"end\":\"12695\",\"attributes\":{\"ref_id\":\"tab_1\"}},{\"start\":\"12880\",\"end\":\"12887\",\"attributes\":{\"ref_id\":\"tab_2\"}},{\"start\":\"13963\",\"end\":\"13971\",\"attributes\":{\"ref_id\":\"tab_3\"}}]", "section_header": "[{\"start\":\"3210\",\"end\":\"3218\"},{\"start\":\"3562\",\"end\":\"3607\"},{\"start\":\"5564\",\"end\":\"5576\"},{\"start\":\"8273\",\"end\":\"8290\"},{\"start\":\"8293\",\"end\":\"8311\"},{\"start\":\"9110\",\"end\":\"9128\"},{\"start\":\"10161\",\"end\":\"10213\"},{\"start\":\"12186\",\"end\":\"12193\"},{\"start\":\"12196\",\"end\":\"12210\"},{\"start\":\"12741\",\"end\":\"12756\"},{\"start\":\"14915\",\"end\":\"14932\"},{\"start\":\"19459\",\"end\":\"19476\"},{\"start\":\"20962\",\"end\":\"20970\"},{\"start\":\"21131\",\"end\":\"21139\"},{\"start\":\"21322\",\"end\":\"21329\"},{\"start\":\"21915\",\"end\":\"21922\"},{\"start\":\"22531\",\"end\":\"22538\"},{\"start\":\"22986\",\"end\":\"22993\"}]", "table": "[{\"start\":\"21374\",\"end\":\"21913\"},{\"start\":\"21979\",\"end\":\"22529\"},{\"start\":\"22569\",\"end\":\"22984\"},{\"start\":\"23136\",\"end\":\"23346\"}]", "figure_caption": "[{\"start\":\"20972\",\"end\":\"21129\"},{\"start\":\"21141\",\"end\":\"21320\"},{\"start\":\"21331\",\"end\":\"21374\"},{\"start\":\"21924\",\"end\":\"21979\"},{\"start\":\"22540\",\"end\":\"22569\"},{\"start\":\"22995\",\"end\":\"23136\"}]", "figure_ref": "[{\"start\":\"12697\",\"end\":\"12712\",\"attributes\":{\"ref_id\":\"fig_0\"}}]", "bib_author_first_name": "[{\"start\":\"24268\",\"end\":\"24269\"},{\"start\":\"24270\",\"end\":\"24271\"},{\"start\":\"24280\",\"end\":\"24281\"},{\"start\":\"24282\",\"end\":\"24283\"},{\"start\":\"24292\",\"end\":\"24293\"},{\"start\":\"24521\",\"end\":\"24522\"},{\"start\":\"24532\",\"end\":\"24533\"},{\"start\":\"24541\",\"end\":\"24542\"},{\"start\":\"24857\",\"end\":\"24858\"},{\"start\":\"24877\",\"end\":\"24878\"},{\"start\":\"24887\",\"end\":\"24888\"},{\"start\":\"24889\",\"end\":\"24890\"},{\"start\":\"25268\",\"end\":\"25269\"},{\"start\":\"25281\",\"end\":\"25284\"},{\"start\":\"25292\",\"end\":\"25293\"},{\"start\":\"25624\",\"end\":\"25625\"},{\"start\":\"25626\",\"end\":\"25627\"},{\"start\":\"25634\",\"end\":\"25635\"},{\"start\":\"25636\",\"end\":\"25637\"},{\"start\":\"26006\",\"end\":\"26007\"},{\"start\":\"26008\",\"end\":\"26009\"},{\"start\":\"26017\",\"end\":\"26018\"},{\"start\":\"26019\",\"end\":\"26020\"},{\"start\":\"26031\",\"end\":\"26032\"},{\"start\":\"26455\",\"end\":\"26456\"},{\"start\":\"26457\",\"end\":\"26458\"},{\"start\":\"26469\",\"end\":\"26470\"},{\"start\":\"26471\",\"end\":\"26472\"},{\"start\":\"26485\",\"end\":\"26486\"},{\"start\":\"26487\",\"end\":\"26488\"},{\"start\":\"26959\",\"end\":\"26960\"},{\"start\":\"26965\",\"end\":\"26966\"},{\"start\":\"26974\",\"end\":\"26975\"},{\"start\":\"27323\",\"end\":\"27324\"},{\"start\":\"27331\",\"end\":\"27333\"},{\"start\":\"27340\",\"end\":\"27341\"},{\"start\":\"27342\",\"end\":\"27343\"},{\"start\":\"27352\",\"end\":\"27353\"},{\"start\":\"27623\",\"end\":\"27625\"},{\"start\":\"27636\",\"end\":\"27637\"},{\"start\":\"27644\",\"end\":\"27645\"},{\"start\":\"27654\",\"end\":\"27655\"},{\"start\":\"27962\",\"end\":\"27963\"},{\"start\":\"27975\",\"end\":\"27976\"},{\"start\":\"27993\",\"end\":\"27996\"},{\"start\":\"28442\",\"end\":\"28443\"},{\"start\":\"28450\",\"end\":\"28451\"},{\"start\":\"28460\",\"end\":\"28461\"},{\"start\":\"28987\",\"end\":\"28988\"},{\"start\":\"28995\",\"end\":\"28996\"},{\"start\":\"29009\",\"end\":\"29010\"},{\"start\":\"29427\",\"end\":\"29428\"},{\"start\":\"29445\",\"end\":\"29446\"},{\"start\":\"29447\",\"end\":\"29448\"},{\"start\":\"29457\",\"end\":\"29458\"},{\"start\":\"29459\",\"end\":\"29460\"},{\"start\":\"29811\",\"end\":\"29812\"},{\"start\":\"29813\",\"end\":\"29814\"},{\"start\":\"29824\",\"end\":\"29825\"},{\"start\":\"29826\",\"end\":\"29827\"},{\"start\":\"29836\",\"end\":\"29837\"},{\"start\":\"30258\",\"end\":\"30259\"},{\"start\":\"30266\",\"end\":\"30267\"},{\"start\":\"30268\",\"end\":\"30269\"},{\"start\":\"30280\",\"end\":\"30281\"},{\"start\":\"30748\",\"end\":\"30749\"},{\"start\":\"30759\",\"end\":\"30760\"},{\"start\":\"30769\",\"end\":\"30770\"},{\"start\":\"31121\",\"end\":\"31122\"},{\"start\":\"31135\",\"end\":\"31136\"},{\"start\":\"31149\",\"end\":\"31150\"},{\"start\":\"31503\",\"end\":\"31506\"},{\"start\":\"31513\",\"end\":\"31514\"},{\"start\":\"31515\",\"end\":\"31516\"},{\"start\":\"31527\",\"end\":\"31530\"},{\"start\":\"31920\",\"end\":\"31921\"},{\"start\":\"31927\",\"end\":\"31928\"},{\"start\":\"31933\",\"end\":\"31934\"},{\"start\":\"32277\",\"end\":\"32278\"},{\"start\":\"32288\",\"end\":\"32289\"},{\"start\":\"32302\",\"end\":\"32303\"},{\"start\":\"32641\",\"end\":\"32642\"},{\"start\":\"32643\",\"end\":\"32644\"},{\"start\":\"32655\",\"end\":\"32656\"},{\"start\":\"32664\",\"end\":\"32665\"},{\"start\":\"32666\",\"end\":\"32667\"},{\"start\":\"33044\",\"end\":\"33045\"},{\"start\":\"33046\",\"end\":\"33047\"},{\"start\":\"33055\",\"end\":\"33058\"},{\"start\":\"33069\",\"end\":\"33070\"},{\"start\":\"33071\",\"end\":\"33072\"}]", "bib_author_last_name": "[{\"start\":\"24272\",\"end\":\"24278\"},{\"start\":\"24284\",\"end\":\"24290\"},{\"start\":\"24294\",\"end\":\"24299\"},{\"start\":\"24523\",\"end\":\"24530\"},{\"start\":\"24534\",\"end\":\"24539\"},{\"start\":\"24543\",\"end\":\"24550\"},{\"start\":\"24859\",\"end\":\"24875\"},{\"start\":\"24879\",\"end\":\"24885\"},{\"start\":\"24891\",\"end\":\"24898\"},{\"start\":\"25270\",\"end\":\"25279\"},{\"start\":\"25285\",\"end\":\"25290\"},{\"start\":\"25294\",\"end\":\"25298\"},{\"start\":\"25628\",\"end\":\"25632\"},{\"start\":\"25638\",\"end\":\"25645\"},{\"start\":\"26010\",\"end\":\"26015\"},{\"start\":\"26021\",\"end\":\"26029\"},{\"start\":\"26033\",\"end\":\"26040\"},{\"start\":\"26459\",\"end\":\"26467\"},{\"start\":\"26473\",\"end\":\"26483\"},{\"start\":\"26489\",\"end\":\"26495\"},{\"start\":\"26961\",\"end\":\"26963\"},{\"start\":\"26967\",\"end\":\"26972\"},{\"start\":\"26976\",\"end\":\"26979\"},{\"start\":\"27325\",\"end\":\"27329\"},{\"start\":\"27334\",\"end\":\"27338\"},{\"start\":\"27344\",\"end\":\"27350\"},{\"start\":\"27626\",\"end\":\"27634\"},{\"start\":\"27638\",\"end\":\"27642\"},{\"start\":\"27646\",\"end\":\"27652\"},{\"start\":\"27964\",\"end\":\"27973\"},{\"start\":\"27977\",\"end\":\"27991\"},{\"start\":\"27997\",\"end\":\"28001\"},{\"start\":\"28444\",\"end\":\"28448\"},{\"start\":\"28452\",\"end\":\"28458\"},{\"start\":\"28462\",\"end\":\"28468\"},{\"start\":\"28989\",\"end\":\"28993\"},{\"start\":\"28997\",\"end\":\"29007\"},{\"start\":\"29011\",\"end\":\"29017\"},{\"start\":\"29429\",\"end\":\"29443\"},{\"start\":\"29449\",\"end\":\"29455\"},{\"start\":\"29461\",\"end\":\"29468\"},{\"start\":\"29815\",\"end\":\"29822\"},{\"start\":\"29828\",\"end\":\"29834\"},{\"start\":\"29838\",\"end\":\"29843\"},{\"start\":\"30260\",\"end\":\"30264\"},{\"start\":\"30270\",\"end\":\"30278\"},{\"start\":\"30282\",\"end\":\"30287\"},{\"start\":\"30750\",\"end\":\"30757\"},{\"start\":\"30761\",\"end\":\"30767\"},{\"start\":\"30771\",\"end\":\"30778\"},{\"start\":\"31123\",\"end\":\"31133\"},{\"start\":\"31137\",\"end\":\"31147\"},{\"start\":\"31151\",\"end\":\"31155\"},{\"start\":\"31507\",\"end\":\"31511\"},{\"start\":\"31517\",\"end\":\"31525\"},{\"start\":\"31531\",\"end\":\"31536\"},{\"start\":\"31922\",\"end\":\"31925\"},{\"start\":\"31929\",\"end\":\"31931\"},{\"start\":\"31935\",\"end\":\"31937\"},{\"start\":\"32279\",\"end\":\"32286\"},{\"start\":\"32290\",\"end\":\"32300\"},{\"start\":\"32304\",\"end\":\"32308\"},{\"start\":\"32645\",\"end\":\"32653\"},{\"start\":\"32657\",\"end\":\"32662\"},{\"start\":\"32668\",\"end\":\"32678\"},{\"start\":\"33040\",\"end\":\"33042\"},{\"start\":\"33048\",\"end\":\"33053\"},{\"start\":\"33059\",\"end\":\"33067\"},{\"start\":\"33073\",\"end\":\"33078\"}]", "bib_entry": "[{\"start\":\"24249\",\"end\":\"24425\",\"attributes\":{\"matched_paper_id\":\"1514000\",\"id\":\"b0\",\"doi\":\"10.3322/caac.21387\"}},{\"start\":\"24427\",\"end\":\"24743\",\"attributes\":{\"matched_paper_id\":\"4503688\",\"id\":\"b1\",\"doi\":\"10.1093/annonc/mdr374\"}},{\"start\":\"24745\",\"end\":\"25159\",\"attributes\":{\"matched_paper_id\":\"10021146\",\"id\":\"b2\",\"doi\":\"10.1016/j.ajog.2013.12.025\"}},{\"start\":\"25161\",\"end\":\"25509\",\"attributes\":{\"matched_paper_id\":\"12755125\",\"id\":\"b3\",\"doi\":\"10.1016/S0140-6736(08)61766-3\"}},{\"start\":\"25511\",\"end\":\"25854\",\"attributes\":{\"matched_paper_id\":\"6014368\",\"id\":\"b4\",\"doi\":\"10.1245/s10434-010-0985-4\"}},{\"start\":\"25856\",\"end\":\"26306\",\"attributes\":{\"matched_paper_id\":\"3790714\",\"id\":\"b5\",\"doi\":\"10.1016/S1470-2045(17)30068-2\"}},{\"start\":\"26308\",\"end\":\"26765\",\"attributes\":{\"matched_paper_id\":\"5144955\",\"id\":\"b6\",\"doi\":\"10.1016/j.ygyno.2017.05.027\"}},{\"start\":\"26767\",\"end\":\"27288\",\"attributes\":{\"matched_paper_id\":\"174809873\",\"id\":\"b7\",\"doi\":\"10.1007/s00404-019-05207-8\"}},{\"start\":\"27290\",\"end\":\"27491\",\"attributes\":{\"matched_paper_id\":\"201831758\",\"id\":\"b8\",\"doi\":\"10.2967/jnumed.118.220582\"}},{\"start\":\"27493\",\"end\":\"27889\",\"attributes\":{\"matched_paper_id\":\"52068791\",\"id\":\"b9\",\"doi\":\"10.1186/s13550-018-0441-1\"}},{\"start\":\"27891\",\"end\":\"28219\",\"attributes\":{\"matched_paper_id\":\"17844884\",\"id\":\"b10\",\"doi\":\"10.1007/s00259-014-2961-x\"}},{\"start\":\"28221\",\"end\":\"28813\",\"attributes\":{\"matched_paper_id\":\"33674865\",\"id\":\"b11\",\"doi\":\"10.1097/IGC.0b013e318253496f\"}},{\"start\":\"28815\",\"end\":\"29304\",\"attributes\":{\"matched_paper_id\":\"3534507\",\"id\":\"b12\",\"doi\":\"10.1245/s10434-015-5022-1\"}},{\"start\":\"29306\",\"end\":\"29713\",\"attributes\":{\"matched_paper_id\":\"40722401\",\"id\":\"b13\",\"doi\":\"10.1016/j.ygyno.2011.04.030\"}},{\"start\":\"29715\",\"end\":\"30054\",\"attributes\":{\"matched_paper_id\":\"4132858\",\"id\":\"b14\",\"doi\":\"10.1016/j.ygyno.2017.05.016\"}},{\"start\":\"30056\",\"end\":\"30602\",\"attributes\":{\"matched_paper_id\":\"47016277\",\"id\":\"b15\",\"doi\":\"10.1016/j.ygyno.2018.06.003\"}},{\"start\":\"30604\",\"end\":\"31034\",\"attributes\":{\"matched_paper_id\":\"184485596\",\"id\":\"b16\",\"doi\":\"10.1016/j.ejca.2019.04.025\"}},{\"start\":\"31036\",\"end\":\"31358\",\"attributes\":{\"matched_paper_id\":\"20449525\",\"id\":\"b17\",\"doi\":\"10.1097/RLU.0000000000000852\"}},{\"start\":\"31360\",\"end\":\"31802\",\"attributes\":{\"matched_paper_id\":\"32943580\",\"id\":\"b18\",\"doi\":\"10.1016/j.radonc.2017.07.013\"}},{\"start\":\"31804\",\"end\":\"32180\",\"attributes\":{\"matched_paper_id\":\"2042470\",\"id\":\"b19\",\"doi\":\"10.1177/0194599816644408\"}},{\"start\":\"32182\",\"end\":\"32506\",\"attributes\":{\"matched_paper_id\":\"174805634\",\"id\":\"b20\",\"doi\":\"10.1093/annonc/mdz173\"}},{\"start\":\"32508\",\"end\":\"32932\",\"attributes\":{\"matched_paper_id\":\"26121973\",\"id\":\"b21\",\"doi\":\"10.1016/j.ygyno.2016.02.018\"}},{\"start\":\"32934\",\"end\":\"33304\",\"attributes\":{\"matched_paper_id\":\"22654971\",\"id\":\"b22\",\"doi\":\"10.1245/s10434-015-5040-z\"}}]", "bib_title": "[{\"start\":\"24249\",\"end\":\"24266\"},{\"start\":\"24427\",\"end\":\"24519\"},{\"start\":\"24745\",\"end\":\"24855\"},{\"start\":\"25161\",\"end\":\"25266\"},{\"start\":\"25511\",\"end\":\"25622\"},{\"start\":\"25856\",\"end\":\"26004\"},{\"start\":\"26308\",\"end\":\"26453\"},{\"start\":\"26767\",\"end\":\"26957\"},{\"start\":\"27290\",\"end\":\"27321\"},{\"start\":\"27493\",\"end\":\"27621\"},{\"start\":\"27891\",\"end\":\"27960\"},{\"start\":\"28221\",\"end\":\"28440\"},{\"start\":\"28815\",\"end\":\"28985\"},{\"start\":\"29306\",\"end\":\"29425\"},{\"start\":\"29715\",\"end\":\"29809\"},{\"start\":\"30056\",\"end\":\"30256\"},{\"start\":\"30604\",\"end\":\"30746\"},{\"start\":\"31036\",\"end\":\"31119\"},{\"start\":\"31360\",\"end\":\"31501\"},{\"start\":\"31804\",\"end\":\"31918\"},{\"start\":\"32182\",\"end\":\"32275\"},{\"start\":\"32508\",\"end\":\"32639\"},{\"start\":\"32934\",\"end\":\"33038\"}]", "bib_author": "[{\"start\":\"24268\",\"end\":\"24280\"},{\"start\":\"24280\",\"end\":\"24292\"},{\"start\":\"24292\",\"end\":\"24301\"},{\"start\":\"24521\",\"end\":\"24532\"},{\"start\":\"24532\",\"end\":\"24541\"},{\"start\":\"24541\",\"end\":\"24552\"},{\"start\":\"24857\",\"end\":\"24877\"},{\"start\":\"24877\",\"end\":\"24887\"},{\"start\":\"24887\",\"end\":\"24900\"},{\"start\":\"25268\",\"end\":\"25281\"},{\"start\":\"25281\",\"end\":\"25292\"},{\"start\":\"25292\",\"end\":\"25300\"},{\"start\":\"25624\",\"end\":\"25634\"},{\"start\":\"25634\",\"end\":\"25647\"},{\"start\":\"26006\",\"end\":\"26017\"},{\"start\":\"26017\",\"end\":\"26031\"},{\"start\":\"26031\",\"end\":\"26042\"},{\"start\":\"26455\",\"end\":\"26469\"},{\"start\":\"26469\",\"end\":\"26485\"},{\"start\":\"26485\",\"end\":\"26497\"},{\"start\":\"26959\",\"end\":\"26965\"},{\"start\":\"26965\",\"end\":\"26974\"},{\"start\":\"26974\",\"end\":\"26981\"},{\"start\":\"27323\",\"end\":\"27331\"},{\"start\":\"27331\",\"end\":\"27340\"},{\"start\":\"27340\",\"end\":\"27352\"},{\"start\":\"27352\",\"end\":\"27356\"},{\"start\":\"27623\",\"end\":\"27636\"},{\"start\":\"27636\",\"end\":\"27644\"},{\"start\":\"27644\",\"end\":\"27654\"},{\"start\":\"27654\",\"end\":\"27658\"},{\"start\":\"27962\",\"end\":\"27975\"},{\"start\":\"27975\",\"end\":\"27993\"},{\"start\":\"27993\",\"end\":\"28003\"},{\"start\":\"28442\",\"end\":\"28450\"},{\"start\":\"28450\",\"end\":\"28460\"},{\"start\":\"28460\",\"end\":\"28470\"},{\"start\":\"28987\",\"end\":\"28995\"},{\"start\":\"28995\",\"end\":\"29009\"},{\"start\":\"29009\",\"end\":\"29019\"},{\"start\":\"29427\",\"end\":\"29445\"},{\"start\":\"29445\",\"end\":\"29457\"},{\"start\":\"29457\",\"end\":\"29470\"},{\"start\":\"29811\",\"end\":\"29824\"},{\"start\":\"29824\",\"end\":\"29836\"},{\"start\":\"29836\",\"end\":\"29845\"},{\"start\":\"30258\",\"end\":\"30266\"},{\"start\":\"30266\",\"end\":\"30280\"},{\"start\":\"30280\",\"end\":\"30289\"},{\"start\":\"30748\",\"end\":\"30759\"},{\"start\":\"30759\",\"end\":\"30769\"},{\"start\":\"30769\",\"end\":\"30780\"},{\"start\":\"31121\",\"end\":\"31135\"},{\"start\":\"31135\",\"end\":\"31149\"},{\"start\":\"31149\",\"end\":\"31157\"},{\"start\":\"31503\",\"end\":\"31513\"},{\"start\":\"31513\",\"end\":\"31527\"},{\"start\":\"31527\",\"end\":\"31538\"},{\"start\":\"31920\",\"end\":\"31927\"},{\"start\":\"31927\",\"end\":\"31933\"},{\"start\":\"31933\",\"end\":\"31939\"},{\"start\":\"32277\",\"end\":\"32288\"},{\"start\":\"32288\",\"end\":\"32302\"},{\"start\":\"32302\",\"end\":\"32310\"},{\"start\":\"32641\",\"end\":\"32655\"},{\"start\":\"32655\",\"end\":\"32664\"},{\"start\":\"32664\",\"end\":\"32680\"},{\"start\":\"33040\",\"end\":\"33044\"},{\"start\":\"33044\",\"end\":\"33055\"},{\"start\":\"33055\",\"end\":\"33069\"},{\"start\":\"33069\",\"end\":\"33080\"}]", "bib_venue": "[{\"start\":\"24319\",\"end\":\"24335\"},{\"start\":\"24573\",\"end\":\"24582\"},{\"start\":\"24926\",\"end\":\"24945\"},{\"start\":\"25329\",\"end\":\"25335\"},{\"start\":\"25672\",\"end\":\"25686\"},{\"start\":\"26071\",\"end\":\"26083\"},{\"start\":\"26524\",\"end\":\"26537\"},{\"start\":\"27007\",\"end\":\"27026\"},{\"start\":\"27381\",\"end\":\"27391\"},{\"start\":\"27683\",\"end\":\"27693\"},{\"start\":\"28028\",\"end\":\"28054\"},{\"start\":\"28498\",\"end\":\"28518\"},{\"start\":\"29044\",\"end\":\"29058\"},{\"start\":\"29497\",\"end\":\"29510\"},{\"start\":\"29872\",\"end\":\"29885\"},{\"start\":\"30316\",\"end\":\"30329\"},{\"start\":\"30806\",\"end\":\"30818\"},{\"start\":\"31185\",\"end\":\"31198\"},{\"start\":\"31566\",\"end\":\"31581\"},{\"start\":\"31963\",\"end\":\"31989\"},{\"start\":\"32331\",\"end\":\"32340\"},{\"start\":\"32707\",\"end\":\"32720\"},{\"start\":\"33105\",\"end\":\"33119\"}]"}}}, "year": 2023, "month": 12, "day": 17}